Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 Notice is hereby given that meeting of the Board of Directors of the Company will be held on Thursday May 21 2026 inter-alia to consider and adopt the audited financial results for the 4th quarter and financial year ended March 31 2026.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
